FibroBiologics, Inc. Common StockFBLGNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank80
3Y CAGR+39.5%
5Y CAGR+78.3%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+39.5%/yr
Annual compound
5Y CAGR
+78.3%/yr
Recent deceleration
Percentile
P80
Within normal range
vs 5Y Ago
18x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$9.01M-2.4%
2024$9.23M+41.6%
2023$6.52M+96.4%
2022$3.32M+214.1%
2021$1.06M+111.4%
2020$500000.00-